- ¥58bn
- ¥48bn
- ¥53bn
- 96
- 71
- 85
- 99
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 11.3 | ||
PEG Ratio (f) | 2.41 | ||
EPS Growth (f) | 4.93% | ||
Dividend Yield (f) | 3.58% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.22 | ||
Price to Tang. Book | 1.32 | ||
Price to Free Cashflow | 10.66 | ||
Price to Sales | 1.05 | ||
EV to EBITDA | 5.55 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 10.99% | ||
Return on Equity | 9.95% | ||
Operating Margin | 11.45% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | ¥m | 39,091.31 | 35,588.52 | 42,337.01 | 48,515.15 | 53,425 | 56,500 | 61,500 | 6.6% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -5.36 | -5.84 | +32.24 | +22.66 | +12.12 | -6.56 | +10.51 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
ANEST IWATA Corporation is a Japan-based manufacturing company. The Company is primarily engaged in the manufacture and sale of compressors, vacuum equipment, as well as painting equipment and facilities. The Company mainly operates its businesses in Italy, France, Germany, China, India and Thailand.
Directors
- Takahiro Tsubota PRE (60)
- Shinichi Fukase SEO
- Hajime Iwata SEO (57)
- Kenichi Ohsawa SEO
- Shinya Tsukamoto SEO (53)
- Eisuke Miyoshi DHR
- Nobukazu Kamehara EXO
- Koichi Takano EXO
- Toshiyuki Iida OTH (58)
- Kiyoshi Morimoto DRC (68)
- Masato Suzuki DRC
- Atsumi Machida IND (62)
- Kyosuke Oshima IND (68)
- Masashige Takayama IND (60)
- Kazumichi Matsuki NID (70)
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- June 2nd, 1948
- Public Since
- December 6th, 1963
- No. of Shareholders
- 4,316
- No. of Employees
- 1,865
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 39,584,486
- Address
- 3176, Shinyoshida-cho, Kohoku-ku, YOKOHAMA-SHI, 223-8501
- Web
- https://www.anest-iwata.co.jp/
- Phone
- +81 455911111
- Auditors
- Seinan Audit Corporation
Upcoming Events for 6381
Dividend For 6381.T - 28.0000 JPY
Similar to 6381
A&D Holon Holdings Co
Tokyo Stock Exchange
Advanex
Tokyo Stock Exchange
Aichi
Tokyo Stock Exchange
Aichi Tokei Denki Co
Tokyo Stock Exchange
Aida Engineering
Tokyo Stock Exchange
FAQ
As of Today at 18:16 UTC, shares in Anest Iwata are trading at ¥1,453. This share price information is delayed by 15 minutes.
Shares in Anest Iwata last closed at ¥1,453 and the price had moved by +33.3% over the past 365 days. In terms of relative price strength the Anest Iwata share price has outperformed the Nikkei 225 Index by +12.05% over the past year.
The overall consensus recommendation for Anest Iwata is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Anest Iwata dividend yield is 3.37% based on the trailing twelve month period.
Last year, Anest Iwata paid a total dividend of ¥49, and it currently has a trailing dividend yield of 3.37%.Looking ahead, shares in Anest Iwata are due to go ex-dividend on 2025-03-28 and the next dividend pay date is 2024-12-09.
Anest Iwata are due to go ex-dividend on 2025-03-28 and the next dividend pay date is 2024-12-09. The historic dividend yield on Anest Iwata shares is currently 3.37%.
To buy shares in Anest Iwata you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥1,453, shares in Anest Iwata had a market capitalisation of ¥58bn.
Here are the trading details for Anest Iwata:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 6381
Based on an overall assessment of its quality, value and momentum Anest Iwata is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Anest Iwata is ¥1,400. That is 3.65% below the last closing price of ¥1,453.
Analysts covering Anest Iwata currently have a consensus Earnings Per Share (EPS) forecast of ¥120 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Anest Iwata. Over the past six months, its share price has underperformed the Nikkei 225 Index by -0.95%.
As of the last closing price of ¥1,453, shares in Anest Iwata were trading +4.24% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Anest Iwata PE ratio based on its reported earnings over the past 12 months is 11.3. The shares last closed at ¥1,453.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Anest Iwata's management team is headed by:
- Takahiro Tsubota - PRE
- Shinichi Fukase - SEO
- Hajime Iwata - SEO
- Kenichi Ohsawa - SEO
- Shinya Tsukamoto - SEO
- Eisuke Miyoshi - DHR
- Nobukazu Kamehara - EXO
- Koichi Takano - EXO
- Toshiyuki Iida - OTH
- Kiyoshi Morimoto - DRC
- Masato Suzuki - DRC
- Atsumi Machida - IND
- Kyosuke Oshima - IND
- Masashige Takayama - IND
- Kazumichi Matsuki - NID